| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,189 | 0,210 | 13:22 | |
| 0,194 | 0,208 | 13:05 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| YONGHE MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| Fr | YONGHE MEDICAL (02279): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 | 1 | HKEx | ||
| 28.10. | YONGHE MEDICAL (02279): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | - | HKEx | ||
| 28.10. | YONGHE MEDICAL (02279): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 28.10. | YONGHE MEDICAL (02279): CHANGE OF COMPOSITION OF NOMINATION COMMITTEE | - | HKEx | ||
| 28.10. | YONGHE MEDICAL (02279): WORKFORCE DIVERSITY POLICY | 1 | HKEx | ||
| 28.10. | YONGHE MEDICAL (02279): BOARD DIVERSITY POLICY | - | HKEx | ||
| 17.09. | YONGHE MEDICAL (02279): INTERIM REPORT 2025 | - | HKEx | ||
| 27.08. | YONGHE MEDICAL (02279): ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | 2 | HKEx | ||
| 15.08. | YONGHE MEDICAL (02279): DATE OF BOARD MEETING | - | HKEx | ||
| 29.07. | BRIEF: Yonghe Medical returns to the black in first half of 2025 | 1 | Bamboo Works | ||
| 29.07. | YONGHE MEDICAL (02279): INSIDE INFORMATION - POSITIVE PROFIT ALERT | 1 | HKEx | ||
| 20.06. | YONGHE MEDICAL (02279): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2025 | 1 | HKEx | ||
| 05.06. | YONGHE MEDICAL (02279): NEXT DAY DISCLOSURE RETURN | 1 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,070 | -0,19 % | Eckert&Ziegler-Aktie schockt still den Markt - erste Marktbeobachter sprechen von einem stillen Wendepunkt - die nächsten Tage könnten brutal werden - in beide Richtungen. | ||
| UNITEDHEALTH | 282,00 | -0,05 % | Wichtige Termine! LVMH, UnitedHealth, Meta, Strategy, Bitcoin im Check | Die Aktienmärkte haben eine schwache Handelswoche hinter sich. Sowohl der DAX als auch die großen US-Indizes gaben in der vergangenen Woche deutlich ab. Immerhin macht die Wall Street mit ihrer Performance... ► Artikel lesen | |
| STRATEC | 21,800 | +2,35 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Stratec von 30 auf 27 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Die jüngst vom Unternehmen gekappten Ziele für... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,004 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| INSULET | 281,60 | -0,95 % | Canaccord Genuity hebt Kursziel für Insulet nach Wachstumsplan auf 432 US-Dollar an | ||
| QUEST DIAGNOSTICS | 166,20 | -0,09 % | Oracle: Board Expanded With Appointment Of Former Quest Diagnostics Chief Stephen Rusckowski | ||
| ROCKWELL MEDICAL | 0,782 | -1,01 % | Rockwell Medical appoints Joe Dawson to board of directors | ||
| DYNAVOX GROUP | 8,440 | -0,82 % | Dynavox Group AB: Dynavox Group Interim Report third quarter 2025 | Dynavox Group AB (publ) today announced its results for the third quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
Our strong growth trajectory continues, maintaining positive momentum... ► Artikel lesen | |
| NYXOAH | 4,250 | +9,40 % | Nyxoah's Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule | Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah's U.S. commercial rollout... ► Artikel lesen | |
| ORASURE TECHNOLOGIES | 2,100 | 0,00 % | OraSure stellt auf Investorenkonferenz strategisches Wachstum und Innovation in den Fokus | ||
| AVANOS MEDICAL | 10,700 | +2,88 % | Avanos Medical, Inc. Announces Third Quarter 2025 Results | Delivered double-digit growth in Specialty Nutrition Systems segment
Closed acquisition of Nexus Medical, providing a complementary technology for the Specialty... ► Artikel lesen | |
| MEDICOVER | 20,650 | -0,96 % | Medicover AB: Interim report July-September 2025 | Third quarterRevenue amounted to €591.6m (€527.8m), an increase of 12.1% with an organic growth of 12.4%.Operating profit (EBIT) was €42.8m (€6.7m), representing an operating margin of 7.2% (1.3%).Net... ► Artikel lesen | |
| SEQUANA MEDICAL | 0,705 | 0,00 % | Sequana Medical NV: Transparency Notification from Shareholders | Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders
Ghent, Belgium - 24 November 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
| GENEDX | 167,52 | 0,00 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| PROGYNY | 26,770 | 0,00 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action |